Professor Richard Grundy
University of Nottingham £110,020 over 3 years
Genome wide molecular characterisation of supratentorial PNET (sPNET)
The management of these tumours remains difficult and patients generally have a poor prognosis. This study aims to find out more about the underlying biology of sPNETS. Recent technology developments have made it possible to analyse the whole human genetic code or genome of many samples in a single experiment. These techniques are extremely powerful as they allow researchers to perform experiments that would previously have taken years, in a matter of weeks. These new technologies will be used to generate the biological data that we desperately need to:
Diagnose sPNETs more accurately
Predict the behaviour of individual sPNETS
Find new targets for sPNETS therapy
Understanding the underlying causes of sPNETS
